academic article

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.  JAMA Oncology.  3. 2017
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.  Oncotarget.  7. 2016
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.  Journal of Medical Genetics.  53. 2016
Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium.  British Journal of Cancer.  115. 2016
Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer.  Nature Communications.  6. 2015
Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer.  Carcinogenesis.  36. 2015
Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study.  Gynecologic Oncology.  136. 2015
Identification of six new susceptibility loci for invasive epithelial ovarian cancer.  Nature Genetics.  47. 2015
Consortium analysis of gene and gene–folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.  Molecular Nutrition & Food Research.  58. 2014